Study affirms the need for prevention and monitoring
Study assesses outcomes of therapies with novel agents
Autologous anti-CD19 agent produces impressive survival improvements
Interim results of phase 2 trial are promising
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes
Study results from ASH 2019 shed light on treatment
Non-home discharge and higher ECOG status associated with IP/IV chemotherapy non-completion
Please join our staff as we participate or present in the following sessions at the 61st American Society of Hematology (ASH) Annual Meeting.
Algorithm reveals many features not appreciated by the unaided eye
Greater weight means less sleep, lower quality of life
Advertisement
Advertisement